| Emily Church, | |
|
584 Old Brunerstown Rd Apt 522, Shelbyville, KY 40065-8476 | |
| (502) 428-1972 | |
| Not Available |
| Full Name | Emily Church |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 584 Old Brunerstown Rd Apt 522, Shelbyville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083882823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 168206 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Church, 584 Old Brunerstown Rd Apt 522, Shelbyville, KY 40065-8476 Ph: () - | Emily Church, 584 Old Brunerstown Rd Apt 522, Shelbyville, KY 40065-8476 Ph: (502) 428-1972 |
News Archive
A large study published in the journal JAMA in March 2020 reports that large pharmaceutical companies make a much larger profit from their products than other large public companies. This is important because it indicates the potential to reduce drug prices while sustaining competitive and innovative drug development and marketing.
Florida has experienced numerous harmful algal blooms in recent years, including blue-green algae and their toxins in 2016 and 2018. Despite their intensity and frequency, there is scant data on human exposure to these blooms and concentrations of the toxins they produce in tissues of exposed individuals.
Janssen R&D Ireland today announced primary efficacy and safety results from two global Phase 3 studies demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 80 and 81 percent, respectively, of treatment-naive genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when administered once daily with pegylated interferon and ribavirin.
The University of Medicine and Dentistry of New Jersey (UMDNJ) announced today that Dr. David Alland, professor of medicine, chief of infectious diseases, and director of the Center for Emerging and Re-Emerging Pathogens at UMDNJ-New Jersey Medical School, will receive a tuberculosis (TB) biomarkers grant awarded by the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.
› Verified 2 days ago
Katie Flanigan, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 Midland Trl, Suite 1 And 2, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-805-1511 | |
Kayleigh Hinton Talbott, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007 | |
Michelle Vogt Smith, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 Midland Trl, Suite 1 And 2, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-805-1511 | |
Anna Nicole Perlack, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007 | |
Alison Yeggy, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007 | |
Hillary Forsee, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-805-1511 | |
Kathryn Mary Noonan, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-437-0624 |